Proto Labs (PRLB)
(Delayed Data from NYSE)
$30.89 USD
+0.29 (0.95%)
Updated Feb 1, 2023 04:00 PM ET
After-Market: $30.28 -0.61 (-1.97%) 7:58 PM ET
3-Hold of 5 3
B Value D Growth F Momentum D VGM
Income Statements
Fiscal Year end for Proto Labs, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | 12/31/18 | |
---|---|---|---|---|---|
Sales | NA | 488 | 434 | 459 | 446 |
Cost Of Goods | NA | 265 | 217 | 223 | 207 |
Gross Profit | NA | 223 | 218 | 235 | 239 |
Selling & Adminstrative & Depr. & Amort Expenses | 0 | 182 | 158 | 155 | 150 |
Income After Depreciation & Amortization | 0 | 40 | 60 | 80 | 89 |
Non-Operating Income | NA | 0 | 3 | 1 | 3 |
Interest Expense | NA | 0 | 0 | 0 | 0 |
Pretax Income | NA | 40 | 63 | 81 | 92 |
Income Taxes | NA | 7 | 12 | 18 | 15 |
Minority Interest | NA | 0 | 0 | 0 | 0 |
Investment Gains/Losses | NA | 0 | 0 | 0 | 0 |
Other Income/Charges | NA | 0 | 0 | 0 | 0 |
Income From Cont. Operations | NA | 33 | 51 | 64 | 77 |
Extras & Discontinued Operations | NA | 0 | 0 | 0 | 0 |
Net Income (GAAP) | NA | 33 | 51 | 64 | 77 |
Depreciation Footnote | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | 12/31/18 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 0 | 81 | 93 | 111 | 116 |
Depreciation & Amortization (Cash Flow) | NA | 40 | 33 | 31 | 27 |
Income After Depreciation & Amortization | 0 | 40 | 60 | 80 | 89 |
Earnings Per Share Data | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | 12/31/18 |
---|---|---|---|---|---|
Average Shares | NA | 27.65 | 26.90 | 27.05 | 27.28 |
Diluted EPS Before Non-Recurring Items | NA | 1.21 | 1.89 | 2.35 | 2.81 |
Diluted Net EPS (GAAP) | NA | 1.21 | 1.89 | 2.35 | 2.81 |
Fiscal Year end for Proto Labs, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/22 | 9/30/22 | 6/30/22 | 3/31/22 | 12/31/21 | |
---|---|---|---|---|---|
Sales | NA | 121.72 | 126.90 | 124.17 | 123.58 |
Cost Of Goods | NA | 68.09 | 69.48 | 68.36 | 68.17 |
Gross Profit | NA | 53.63 | 57.42 | 55.80 | 55.41 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 47.58 | 52.22 | 47.92 | 42.37 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 6.05 | 5.20 | 7.88 | 13.04 |
Non-Operating Income | NA | -0.02 | 0.00 | -0.30 | -0.12 |
Interest Expense | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Pretax Income | NA | 6.03 | 5.20 | 7.59 | 12.93 |
Income Taxes | NA | 2.08 | 2.65 | 2.50 | 1.02 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | 3.95 | 2.56 | 5.10 | 11.91 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | 3.95 | 2.56 | 5.10 | 11.91 |
Earnings Per Share Data | 12/31/22 | 9/30/22 | 6/30/22 | 3/31/22 | 12/31/21 |
---|---|---|---|---|---|
Average Shares | NA | 27.51 | 27.54 | 27.51 | 27.56 |
Diluted EPS Before Non-Recurring Items | NA | 0.14 | 0.09 | 0.19 | 0.43 |
Diluted Net EPS (GAAP) | NA | 0.14 | 0.09 | 0.19 | 0.44 |